TrialHypertension research : official journal of the Japanese Society of Hypertension2024
Impact of first-line antihypertensive drug class and intensity on NT-proBNP improvement and cardiovascular outcomes among hypertensive patients with pre-heart failure: findings from SPRINT trial.
Lili Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it